HCA Healthcare, Inc. $HCA Shares Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 285,650 shares of the company’s stock after purchasing an additional 19,023 shares during the quarter. Hsbc Holdings PLC’s holdings in HCA Healthcare were worth $133,410,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in HCA. State Street Corp lifted its holdings in shares of HCA Healthcare by 1.0% during the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after acquiring an additional 76,039 shares in the last quarter. Capital World Investors raised its position in HCA Healthcare by 0.8% in the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after purchasing an additional 40,086 shares during the period. Geode Capital Management LLC lifted its stake in shares of HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after purchasing an additional 13,565 shares in the last quarter. Norges Bank acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at about $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership lifted its position in HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after acquiring an additional 245,887 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA opened at $375.37 on Monday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The company has a 50-day moving average of $419.68 and a 200-day moving average of $468.81. The company has a market capitalization of $83.27 billion, a P/E ratio of 12.91, a PEG ratio of 1.19 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same quarter last year, the business posted $6.45 earnings per share. The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft reduced their target price on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research report on Tuesday, April 28th. Robert W. Baird dropped their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Sanford C. Bernstein lowered their target price on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a research note on Thursday, June 4th. Weiss Ratings cut HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Finally, Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Fifteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.